Ulysses Neuroscience
PrivateLast Round
Early Funding
Apr 17, 2024
Total Funding Raised
$530,000
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Ulysses Neuroscience operates in Healthcare & Life Sciences and is based in Dublin. Its latest recorded funding round was an Early Funding round in April 2024.
Ulysses Neuroscience is a contract research organization that provides preclinical and clinical research services to pharmaceutical and biotech companies to accelerate drug discovery for neuropsychiatric, neurodegenerative, and rare neurological disorders.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Clinical Trials, Biotechnology, Precision Medicine, Mental Health
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ulysses Neuroscience Comparables
Compare Ulysses Neuroscience with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Vivocore Inc. | 84% | |
| MD Biosciences | 82% | |
| Neuroservices-Alliance | 80% |
For institutional investors. Book with your work email.
Ulysses Neuroscience Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Ulysses Neuroscience Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Growing Capital | Early Funding |
| Enterprise Ireland | Early Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 23, 2026
Grew 33% QoQ from 15 to 20 employees.
- Mar 3, 2026
Grew 36% QoQ from 11 to 15 employees.
For institutional investors. Book with your work email.
Ulysses Neuroscience Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Ulysses Neuroscience's valuation, stock price, and market status.
Is Ulysses Neuroscience a public or private company?
Ulysses Neuroscience is a private company.
What is the current stock price of Ulysses Neuroscience?
Ulysses Neuroscience is a private company, so its shares have no public market price. Caplight tracks Ulysses Neuroscience's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Ulysses Neuroscience worth (valuation)?
Valuation information for Ulysses Neuroscience is not publicly available.
Can I buy Ulysses Neuroscience stock?
Ulysses Neuroscience shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Ulysses Neuroscience's last funding round?
Ulysses Neuroscience's most recent funding round was Early Funding on April 17, 2024.
Who are the main investors in Ulysses Neuroscience?
Key investors in Ulysses Neuroscience include Growing Capital, Enterprise Ireland.
Will Ulysses Neuroscience IPO soon?
No public IPO plans have been announced for Ulysses Neuroscience.
How can I track Ulysses Neuroscience secondary market activity?
Caplight tracks bids, offers, and trades in Ulysses Neuroscience's shares on secondary markets.